Oil prices slip as weak China exports highlight trade war impact
December 9, 2019
Trial begins in U.S. states’ effort to block T-Mobile/Sprint deal
December 9, 2019

France’s Sanofi to buy biotech firm Synthorx for $2.5 billion

Sanofi said on Monday it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion aimed at beefing up the French drugmaker’s pipeline of drugs for cancer and auto-immune disorders.

Powered by WPeMatico